Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats

AIM: Blocking of lysophosphatidic acid (LPA) receptor (LPAR) 1 may be a novel therapeutic option for bronchopulmonary dysplasia (BPD) by preventing the LPAR1-mediated adverse effects of its ligand (LPA), consisting of lung inflammation, pulmonary arterial hypertension (PAH) and fibrosis. METHODS: In...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Acta Physiol (Oxf)
Päätekijät: Chen, Xueyu, Walther, Frans J, van Boxtel, Ruben, Laghmani, El Houari, Sengers, Rozemarijn M A, Folkerts, Gert, DeRuiter, Marco C., Cuppen, Edwin, Wagenaar, Gerry T M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4738067/
https://ncbi.nlm.nih.gov/pubmed/26495902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apha.12622
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia